FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to oxazolopyramidine compounds of formula 
I, where A represents O; R1 is selected from phenyl or pyrimidine, which are optionally substituted with R11; R2 represents phenyl, which is optionally substituted wby 1-3 ring carbon atoms with similar or different substituents R22, R11 represents halogen; R22 is selected from hydroxy group, (C1-C4)-alkyl, which is optionallysubstituted with 1-3 atoms of fluorine, (C1-C4)-alkyloxy, (C1-C4)-alkyl-S(O)m-; m equals 2. Invention also relates to pharmaceutical composition, which contains formula I compounds, and to method of obtaining formula I compounds.
EFFECT: formula I compounds, intended for activation of EDG-1 receptor and applied for wound healing.
15 cl, 2 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| 2,5,7-SUBSTITUTED OXAZOLPYRIMIDINE DERIVATIVES | 2011 |
|
RU2557246C2 |
| HETEROCYCLIC CARBOXYLIC ACID DERIVATIVES HAVING 2,5-SUBSTITUTED OXAZOLOPYRIMIDINE RING | 2011 |
|
RU2559896C2 |
| CARBOXYLIC ACID DERIVATIVES CONTAINING 2,5,7-SUBSTITUTED OXAZOLE PYRIMIDINE RING | 2011 |
|
RU2560876C2 |
| CARBOXYLIC ACID DERIVATIVES CONTAINING 2,5-SUBSTITUTED OXAZOLOPYRIMIDINE RING | 2011 |
|
RU2564018C2 |
| DERIVATIVE OF HETEROCYCLIC CARBON ACIDS, WHICH CONTAIN 2,5,7-SUBSTITUTED OXAZOLOPYRIMIDINE RING | 2011 |
|
RU2554869C2 |
| DERIVATIVES OF CARBOXYLIC ACIDS WITH OXAZOLE[4,5-c]PYRIDINE CYCLE | 2012 |
|
RU2609004C2 |
| DERIVATIVES OF CARBOXYLIC ACIDS WITH OXAZOLE[5,4-b]PYRIDINE RING | 2012 |
|
RU2609002C2 |
| ACYLAMINO-SUBSTITUTED DERIVATIVES OF CONDENSED CYCLOPENTACARBOXYLIC ACIDS AND THEIR APPLICATION AS PHARMACEUTICALS | 2009 |
|
RU2529484C2 |
| INHIBITORS OF FACTOR VIIA | 2000 |
|
RU2248359C2 |
| CARBOXYLIC ACID DERIVATIVES, HAVING OXAZOLE[4,5-D]PYRIMIDINE RING | 2012 |
|
RU2609003C2 |
